Supporting evidence from glioblastoma stem cells shows that POSTN enhances self-renewal and malignancy via activation of the αvβ3/PI3K/AKT/β-catenin/FOSL1 pathway, upregulating key stemness markers such as CD133, Nestin, and SOX239. The gene discussed is NES; the disease is glioblastoma.